Source: Annual Congress 2009 - Pulmonary hypertension
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Mogulkoc, S. Bayraktaroglu, A. Dirican, M. Kayikcioglu, Y. Kabasakal (Bornova-Izmir, Turkey). A study of pulmonary parenchymal and vascular disease in patients with familial Mediterranean fever (fmf). Eur Respir J 2009; 34: Suppl. 53, 3893

Member's Comments

No comment yet.

Related content which might interest you: Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19. Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 Prevalence of pulmonary hypertension in a large cohort of patients with hereditary hemorrhagic telangiectasia Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 The burden of pulmonary hypertension Source: Annual Congress 2006 - The burden of pulmonary hypertension Year: 2006 Central European idiopathic pulmonary fibrosis (IPF) patients survey Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020 Year: 2020 Comparison between the HRCT manifestations of thoracic involvement in collagen vascular diseases (CVD) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2001; 18: Suppl. 33, 225s Year: 2001 Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF) Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 An evaluation of dietary pattern of chronic obstructive pulmonary disease patients in northern India Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung Year: 2009 A cohort of patients with a progressive fibrosing phenotype of interstitial lung disease (PF-ILD) other than idiopathic pulmonary fibrosis (IPF): the PROGRESS study Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 A vasomotor form of the endothelial dysfunction of the microvasculature in patients with a chronic obstructive pulmonary disease, and in combination with the pulmonary embolism Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 A comparative histological study of pulmonary vascular lesions in lungs of patients With idiopathic or heritable PAH Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 55 (6) 2000041; 10.1183/13993003.00041-2020 Year: 2020 Phenotype of patients with severe pulmonary hypertension secondary to chronic obstructive pulmonary disease: A multicentre study. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Characteristics of idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue disease (APAH-CTD) patients in PROSPECT Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Interstitial lung disease Source: Eur Respir Rev 2013; 22: 26-32 Year: 2013 Pulmonary hypertension associated with myeloproliferative disorders suggesting pulmonary veno-occlusive disease: a retrospective study of six cases Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Pulmonary hypertension (PH) and features of pulmonary circulation in patient with lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 354s Year: 2006 How to detect disease progression in pulmonary arterial hypertension Source: Eur Respir Rev 2012; 21: 40-47 Year: 2012